170 related articles for article (PubMed ID: 18636785)
21. Signal mining and analysis for central nervous system adverse events due to taking oxycodone based on FAERS database.
Wu X; Zhang L; Huang H; Huang L; Lu X; Wang Z; Xiao J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):422-434. PubMed ID: 37164926
[TBL] [Abstract][Full Text] [Related]
22. Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the Vaccine Adverse Event Reporting System (VAERS), 2009-2015.
Arana JE; Harrington T; Cano M; Lewis P; Mba-Jonas A; Rongxia L; Stewart B; Markowitz LE; Shimabukuro TT
Vaccine; 2018 Mar; 36(13):1781-1788. PubMed ID: 29477308
[TBL] [Abstract][Full Text] [Related]
23. Infant immunization with acellular pertussis vaccines in the United States: assessment of the first two years' data from the Vaccine Adverse Event Reporting System (VAERS).
Braun MM; Mootrey GT; Salive ME; Chen RT; Ellenberg SS
Pediatrics; 2000 Oct; 106(4):E51. PubMed ID: 11015546
[TBL] [Abstract][Full Text] [Related]
24. Data mining for adverse drug reaction signals of daptomycin based on real-world data: a disproportionality analysis of the US Food and Drug Administration adverse event reporting system.
Chen JJ; Huo XC; Wang SX; Wang F; Zhao Q
Int J Clin Pharm; 2022 Dec; 44(6):1351-1360. PubMed ID: 36178607
[TBL] [Abstract][Full Text] [Related]
25. Postmarketing safety of anaplastic lymphoma kinase (ALK) inhibitors: an analysis of the FDA Adverse Event Reporting System (FAERS).
Omar NE; Fahmy Soliman AI; Eshra M; Saeed T; Hamad A; Abou-Ali A
ESMO Open; 2021 Dec; 6(6):100315. PubMed ID: 34864500
[TBL] [Abstract][Full Text] [Related]
26. Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020 - October 2021.
Moro PL; Olson CK; Clark E; Marquez P; Strid P; Ellington S; Zhang B; Mba-Jonas A; Alimchandani M; Cragan J; Moore C
Vaccine; 2022 May; 40(24):3389-3394. PubMed ID: 35489985
[TBL] [Abstract][Full Text] [Related]
27. Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990-2018.
Su JR; McNeil MM; Welsh KJ; Marquez PL; Ng C; Yan M; Cano MV
Vaccine; 2021 Jan; 39(5):839-845. PubMed ID: 33422381
[TBL] [Abstract][Full Text] [Related]
28. Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007.
Niu MT; Ball R; Woo EJ; Burwen DR; Knippen M; Braun MM;
Vaccine; 2009 Jan; 27(2):290-7. PubMed ID: 18992783
[TBL] [Abstract][Full Text] [Related]
29. Understanding vaccine safety information from the Vaccine Adverse Event Reporting System.
Varricchio F; Iskander J; Destefano F; Ball R; Pless R; Braun MM; Chen RT
Pediatr Infect Dis J; 2004 Apr; 23(4):287-94. PubMed ID: 15071280
[TBL] [Abstract][Full Text] [Related]
30. Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2015.
Miller ER; Lewis P; Shimabukuro TT; Su J; Moro P; Woo EJ; Jankosky C; Cano M
Hum Vaccin Immunother; 2018; 14(8):1963-1969. PubMed ID: 29580194
[TBL] [Abstract][Full Text] [Related]
31. Optimization of a quantitative signal detection algorithm for spontaneous reports of adverse events post immunization.
Van Holle L; Bauchau V
Pharmacoepidemiol Drug Saf; 2013 May; 22(5):477-87. PubMed ID: 23255430
[TBL] [Abstract][Full Text] [Related]
32. Hearing disorder following COVID-19 vaccination: A pharmacovigilance analysis using the Vaccine Adverse Event Reporting System.
Chen C; Fu F; Ding L; Xiao J
J Clin Pharm Ther; 2022 Nov; 47(11):1789-1795. PubMed ID: 36089844
[TBL] [Abstract][Full Text] [Related]
33. Data mining in the US using the Vaccine Adverse Event Reporting System.
Iskander J; Pool V; Zhou W; English-Bullard R;
Drug Saf; 2006; 29(5):375-84. PubMed ID: 16689554
[TBL] [Abstract][Full Text] [Related]
34. Adverse events after Fluzone ® Intradermal vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), 2011-2013.
Moro PL; Harrington T; Shimabukuro T; Cano M; Museru OI; Menschik D; Broder K
Vaccine; 2013 Oct; 31(43):4984-7. PubMed ID: 23994022
[TBL] [Abstract][Full Text] [Related]
35. Identifying adverse events of vaccines using a Bayesian method of medically guided information sharing.
Crooks CJ; Prieto-Merino D; Evans SJ
Drug Saf; 2012 Jan; 35(1):61-78. PubMed ID: 22136183
[TBL] [Abstract][Full Text] [Related]
36. No evident association between efavirenz use and suicidality was identified from a disproportionality analysis using the FAERS database.
Napoli AA; Wood JJ; Coumbis JJ; Soitkar AM; Seekins DW; Tilson HH
J Int AIDS Soc; 2014; 17(1):19214. PubMed ID: 25192857
[TBL] [Abstract][Full Text] [Related]
37. Preparation for global introduction of inactivated poliovirus vaccine: safety evidence from the US Vaccine Adverse Event Reporting System, 2000-12.
Iqbal S; Shi J; Seib K; Lewis P; Moro PL; Woo EJ; Shimabukuro T; Orenstein WA
Lancet Infect Dis; 2015 Oct; 15(10):1175-1182. PubMed ID: 26289956
[TBL] [Abstract][Full Text] [Related]
38. Medication errors reported to the vaccine adverse event reporting system (VAERS).
Varricchio F
Vaccine; 2002 Aug; 20(25-26):3049-51. PubMed ID: 12163255
[No Abstract] [Full Text] [Related]
39. The upper bound to the Relative Reporting Ratio-a measure of the impact of the violation of hidden assumptions underlying some disproportionality methods used in signal detection.
Van Holle L; Bauchau V
Pharmacoepidemiol Drug Saf; 2014 Aug; 23(8):787-94. PubMed ID: 24395594
[TBL] [Abstract][Full Text] [Related]
40. Mining adverse events in large frequency tables with ontology, with an application to the vaccine adverse event reporting system.
Zhao B; Zhao L
Stat Med; 2023 May; 42(10):1512-1524. PubMed ID: 36791465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
